IRVINE , Calif. & BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that Richard (”Rick”) Lewis, M.D., has joined the Company as its Chief Medical Officer. This is a part-time position reporting directly to Vicente Anido, Jr., Ph.D., Aerie’s Chairman and Chief Executive Officer. Dr. Lewis is a world-renowned leader in ophthalmology, particularly in glaucoma. In addition to his clinical practice in Sacramento, California, and his active involvement in clinical research, he is also on the Executive Committee of the American Society of Cataract and Refractive Surgery, known as ASCRS. He is also past president of the American Glaucoma Society.
Help employers find you! Check out all the jobs and post your resume.
